BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND HMGA2, HMGI-C, 8091, ENSG00000149948, LIPO, HMGIC, BABL AND Treatment
37 results:

  • 1. Folate-modified liposomes mediate the co-delivery of cisplatin with miR-219a-5p for the targeted treatment of cisplatin-resistant lung cancer.
    Wu Y; Zhang J; Zhao J; Wang B
    BMC Pulm Med; 2024 Apr; 24(1):159. PubMed ID: 38561695
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Bioinformatics and Experimental Validation for Identifying Biomarkers Associated with AMG510 (Sotorasib) Resistance in KRAS
    Lin P; Cheng W; Qi X; Zhang P; Xiong J; Li J
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338834
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Blocking tumor-platelet crosstalk to prevent tumor metastasis via reprograming glycolysis using biomimetic membrane-hybridized liposomes.
    Zhu J; Wang R; Yang C; Shao X; Zhang Y; Hou J; Gao Y; Ou A; Chen M; Huang Y
    J Control Release; 2024 Feb; 366():328-341. PubMed ID: 38168561
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. IFNγ blockade in capillary leak site improves tumour chemotherapy by inhibiting lactate-induced endocytosis of vascular endothelial-cadherins.
    Wang R; Ni C; Lou X; Zhang L; Wang L; Yao X; Duan X; Wan J; Li P; Qin Z
    Int J Biol Sci; 2023; 19(5):1490-1508. PubMed ID: 37056922
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A Novel Tri-Functional liposome Re-Educates "Cold Tumor" and Abrogates Tumor Growth by Synergizing Autophagy Inhibition and PD-L1 Blockade.
    Zhou F; Li X; Xue X; Li S; Fan G; Cai Y; Chang Z; Qu J; Liu R
    Adv Healthc Mater; 2023 Apr; 12(11):e2202757. PubMed ID: 36652763
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A novel saponin liposomes based on the couplet medicines of
    Guo C; Su Y; Wang H; Cao M; Diao N; Liu Z; Chen D; Kong M
    Drug Deliv; 2022 Dec; 29(1):2743-2750. PubMed ID: 35999702
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. KRAS-G12D mutation drives immune suppression and the primary resistance of anti-PD-1/PD-L1 immunotherapy in non-small cell lung cancer.
    Liu C; Zheng S; Wang Z; Wang S; Wang X; Yang L; Xu H; Cao Z; Feng X; Xue Q; Wang Y; Sun N; He J
    Cancer Commun (Lond); 2022 Sep; 42(9):828-847. PubMed ID: 35811500
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The combination of MnO
    Zhang J; Xu L; Hu H; Chen E
    Drug Deliv; 2022 Dec; 29(1):466-477. PubMed ID: 35147070
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. liposome nano-formulation with cationic polar lipid DOTAP and cholesterol as a suitable pH-responsive carrier for molecular therapeutic drug (all-trans retinoic acid) delivery to lung cancer cells.
    Grace VMB; Wilson DD; Guruvayoorappan C; Danisha JP; Bonati L
    IET Nanobiotechnol; 2021 Jun; 15(4):380-390. PubMed ID: 34694713
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Circ_0001666 promotes the proliferation and inhibits apoptosis of non-small cell lung cancer cells by targeting the miR-330-5p/hmga2 axis].
    Xiang BL; Su J; Liu Y
    Sheng Li Xue Bao; 2021 Jun; 73(3):491-500. PubMed ID: 34230950
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. A Blood-based Assay for Assessment of Tumor Mutational Burden in First-line Metastatic NSCLC treatment: Results from the MYSTIC Study.
    Si H; Kuziora M; Quinn KJ; Helman E; Ye J; Liu F; Scheuring U; Peters S; Rizvi NA; Brohawn PZ; Ranade K; Higgs BW; Banks KC; Chand VK; Raja R
    Clin Cancer Res; 2021 Mar; 27(6):1631-1640. PubMed ID: 33355200
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Leukocyte-Mimetic liposomes Penetrate Into Tumor Spheroids and Suppress Spheroid Growth by Encapsulated Doxorubicin.
    Fukuta T; Yoshimi S; Kogure K
    J Pharm Sci; 2021 Apr; 110(4):1701-1709. PubMed ID: 33129835
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Knockdown of MSI2 inhibits metastasis by interacting with caveolin-1 and inhibiting its ubiquitylation in human NF1-MPNST cells.
    Yang K; Du J; Shi D; Ji F; Ji Y; Pan J; Lv F; Zhang Y; Zhang J
    Cell Death Dis; 2020 Jun; 11(6):489. PubMed ID: 32606289
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Biomimetic Decoy Inhibits Tumor Growth and lung Metastasis by Reversing the Drawbacks of Sonodynamic Therapy.
    Zhao H; Zhao B; Li L; Ding K; Xiao H; Zheng C; Sun L; Zhang Z; Wang L
    Adv Healthc Mater; 2020 Jan; 9(1):e1901335. PubMed ID: 31762228
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Self-assembly of mitochondria-specific peptide amphiphiles amplifying lung cancer cell death through targeting the VDAC1-hexokinase-II complex.
    Liu D; Angelova A; Liu J; Garamus VM; Angelov B; Zhang X; Li Y; Feger G; Li N; Zou A
    J Mater Chem B; 2019 Jul; 7(30):4706-4716. PubMed ID: 31364685
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Long non‑coding RNA DANCR promotes hmga2‑mediated invasion in lung adenocarcinoma cells.
    Zhang N; Jiang W
    Oncol Rep; 2019 Feb; 41(2):1083-1090. PubMed ID: 30535487
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Comparison of the genomic background of MET-altered carcinomas of the lung: biological differences and analogies.
    Castiglione R; Alidousty C; Holz B; Wagener S; Baar T; Heydt C; Binot E; Zupp S; Kron A; Wolf J; Merkelbach-Bruse S; Reinhardt HC; Buettner R; Schultheis AM
    Mod Pathol; 2019 May; 32(5):627-638. PubMed ID: 30459450
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Effects of hmga2 gene downregulation by siRNA on lung carcinoma cell migration in A549 cell lines.
    Naghizadeh S; Mansoori B; Mohammadi A; Kafil HS; Mousavi Z; Sakhinia E; Baradaran B
    J Cell Biochem; 2019 Apr; 120(4):5024-5032. PubMed ID: 30317663
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Folate receptor-mediated celastrol and irinotecan combination delivery using liposomes for effective chemotherapy.
    Soe ZC; Thapa RK; Ou W; Gautam M; Nguyen HT; Jin SG; Ku SK; Oh KT; Choi HG; Yong CS; Kim JO
    Colloids Surf B Biointerfaces; 2018 Oct; 170():718-728. PubMed ID: 30005409
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Health care disparities among octogenarians and nonagenarians with stage III lung cancer.
    Cassidy RJ; Zhang X; Switchenko JM; Patel PR; Shelton JW; Tian S; Nanda RH; Steuer CE; Pillai RN; Owonikoko TK; Ramalingam SS; Fernandez FG; Force SD; Gillespie TW; Curran WJ; Higgins KA
    Cancer; 2018 Feb; 124(4):775-784. PubMed ID: 29315497
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.